Larry Michael Mertz - 20 May 2024 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role
Chief Technology Officer
Signature
/s/ David Patience, attorney-in-fact
Issuer symbol
AXDX
Transactions as of
20 May 2024
Transactions value $
-$318
Form type
4
Filing time
21 May 2024, 19:03:03 UTC
Previous filing
10 Apr 2024
Next filing
30 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXDX Common Stock Options Exercise $0 +1K +1.23% $0.00 82.1K 20 May 2024 Direct F1
transaction AXDX Common Stock Sale -$242 -275 -0.33% $0.88 81.8K 20 May 2024 Direct F4
transaction AXDX Common Stock Options Exercise $0 +283 +0.35% $0.00 82.1K 20 May 2024 Direct F1
transaction AXDX Common Stock Sale -$76 -86 -0.1% $0.88 82K 20 May 2024 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXDX Employee Restricted Stock Units Options Exercise $0 -1K -100% $0.00* 0 20 May 2024 Common Stock 1K Direct F1, F2
transaction AXDX Employee Restricted Stock Units Options Exercise $0 -283 -100% $0.00* 0 20 May 2024 Common Stock 283 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting
F2 On May 20, 2021, the reporting person was granted a total of 3,000 RSUs, which vest in equal amounts every year over three years, which started vesting on May 20, 2022.
F3 On May 20, 2021, the reporting person was granted a total of 850 RSUs, which vest in equal amounts every year over three years, which started vesting on May 20, 2022.
F4 The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.